Stay updated with breaking news from Exome Sequencing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Verified Market Research recently published a report, "Geosynthetics Market" By Function (Separation, Drainage, Filtration), By Application...
Dublin, June 10, 2021 (GLOBE NEWSWIRE) -- The "Rare Disease Genetic Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report...
Study: Lung squamous patients harboring druggable mutations have lower median overall survival Oncotarget published " Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations" which reported that unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients. The authors performed survival analyses of lung squamous cell carcinoma patients harboring therapeutically relevant alterations identified by whole exome sequencing and mass spectrometry-based validation across 43...
Whole Exome Sequencing Market is expected to reach US$ 153,689.9 Mn by 2027 With Thermo Fisher Scientific Inc., Illumina, Inc., Centogene AG, F. Hoffmann-L
Neuberg Diagnostics launches clinical laboratory in the US May 03, 2021 × Introduces Covid-19 molecular testing to detect active SARS CoV-2 virus infections that is of immediate public health priority in North America Chennai-based Neuberg Diagnostics on Monday announced the start of its clinical laboratory operations in North Carolina in the US. The North Carolina laboratory, known as NCGM Inc (Neuberg Centre for Genomic Medicine), will focus on genomic and molecular testing based on new generation sequencing techniques. In a press release, the Diagnostics group said, NCGM has introduced...